DempoChem draws on proven expertise from 300+ clinical programs to deliver customized manufacturing solutions aligned with your drug development journey. From preclinical formulation to commercial scale-up, our stage-specific methodologies ensure cGMP-compliant production with risk-mitigated workflows that maintain product integrity.
DempoChem's 20+ strategic alliances with global innovators have enabled us to refine GMP-certified manufacturing platforms spanning registered starting materials (RSMs), advanced intermediates, and APIs. This collaborative ecosystem supports therapeutic programs across neurology, oncology, and rare diseases, with dedicated containment technologies for high-potency compounds.
Our accelerated development pathway delivers cGMP materials for early-phase trials within 14-week lead times. Cross-functional teams execute QbD-driven process development from lead optimization through IND-enabling studies, integrating:
· Phase-appropriate process characterization (DoE-based)
· ICH-compliant analytical method lifecycle management
· Closed-system isolator technology for potent API handling
· End-to-end cold chain solutions (-70°C storage/distribution)
DempoChem leverages an extensive supplier network to meet increasing demand as candidates progress through clinical stages. With multiple cGMP-certified sites, we can manufacture at various scales, from grams to metric tons. Our structured project management approach ensures consistent guidance and continuity throughout the program's lifecycle.
Tell us what you need to make, source, or scale. Our team will route your request to the right specialist.